newsfilter
← Latest News
Business Wire·

Revance Appoints Erica Jordan as Chief Commercial Officer, Aesthetics

Revance Therapeutics, Inc. (NASDAQ:RVNC) today announced the appointment of Erica Jordan, Senior Vice President of Commercial to Chief Commercial Officer (CCO), Aesthetics. As CCO, Erica will have global responsibility